Share
Journal Information
Issue
Vol. 43. Issue S3.
Pages Z1-Z6
(November 2021)
Speaker presentations
Speaker presentations
Pediatric presentations
Oral presentations
THE IMPACT OF TYROSINE KINASE INHIBITORS ON FATHERHOOD IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA, A SINGLE INSTITUTION EXPERIENCE
Mohammad Abu-Tineh, Awni Alshurafa, Elrazi Awadelkarim Hamid Ali, Ashraf Omer Elamin Ahmed, Khalid Mohamed Ibrahim Alhaj ALbsheer, Yousef Hailan, Waail Rozi, Abdulqader Nashwan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S15
Open access
CLINICAL CHARACTERISTICS, AND SURVIVAL RATE OF ELDERLY PATIENTS WITH NON-HODGKIN'S LYMPHOMAS WITH PRIMARY INVOLVEMENT OF PERIPHERAL LYMPH NODES
Tomacinschii Victor, Buruiana Sanda, Robu Maria
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16
Open access
UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT
Carlos CHIATTONE, Eliana MIRANDA, Marcia DELAMAIN, Juliana PEREIRA, Natalia ZING, Danielle FARIAS, Guilherme DUFFLES, Marcelo BELLESSO, ... Carmino SOUZA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S16-S17
Open access
IMPACT OF BONE MARROW FIBROSIS IN MYELOMA PATIENTS UNDERGONE AUTOLOGOUS STEM CELL TRANSPLANTATION
Senem Maral, Murat Albayrak, Gülten Korkmaz, Simten Dagdas, Berna Afacan Öztürk, Aynur Albayrak, Ünsal Han, Merih Reis Aras, Gülsüm Özet
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17
Open access
INVESTIGATION OF THE QUALIFICATION OF RADIOLOGICAL TECHNIQUES TO DETECT OSTEOLYTIC LESIONS, FRACTURES, AND OSTEOPOROSIS IN MULTIPLE MYELOMA PATIENTS
Atakan Turgutkaya, İrfan Yavaşoğlu, Tuğba Şahin, Ali Zahit Bolaman
Hematol Transfus Cell Ther. 2021;43 Supl 3:S17-S18
Open access
ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: IKEMA SUBGROUP ANALYSIS
Mehmut TURGUT, Roman HAJEK, Tomas JELÍNEK, Philippe MOREAU, Thomas MARTIN, Ludek POUR, Gabor MIKALA, Argiris SYMEONIDIS, ... Ivan SPICKA
Hematol Transfus Cell Ther. 2021;43 Supl 3:S18
Open access
DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
Waail Rozi, Elrazi Ali, Alaa Rahhal, Abdulrahman Al-Mashdali, Yousef Hailan, Mohamed Yassin
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19
Open access
THE IMPACT OF HEMATOLOGICAL PARAMETERS ON SURVIVAL FOR PATIENTS WITH COVID-19
Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Ümit Yavuz MALKAN, Pınar AKYOL, Merih REİS ARAS, ... Mesut TIĞLIOĞLU
Hematol Transfus Cell Ther. 2021;43 Supl 3:S19-S20
Open access
AN UNUSUAL SURVIVING HISTORY: MULTISYSTEM INVOLVEMENT UNTIL ADULT LIFE WITH NIEMANN PICK TYPE B
Özden ÖZLÜK, Metban GÜZEL MASTANZADE, Beyza ŞEN OLUK, Sevgi KALAYOĞLU BEŞIŞIK, Bezirgen BALLYYEV
Hematol Transfus Cell Ther. 2021;43 Supl 3:S20
Open access
B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
Svetlana Chulkova, Nikolai Tupitsyn
Hematol Transfus Cell Ther. 2021;43 Supl 3:S21
Open access
COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
Can Alp GENÇ, Dilek GURLEK GOKCEBAY, Vildan KOSAN CULHA, Yasin KOKSAL, Zühre Kaya, Namık Yasar Ozbek
Hematol Transfus Cell Ther. 2021;43 Supl 3:S21-S22
Open access
THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
Barış YILMAZ, Ahmet KOÇ, Ömer DOĞRU, Burcu TUFAN TAŞ, Rabia Emel ŞENAY, Nurşah EKER, Ayşe Gülnur TOKUÇ
Hematol Transfus Cell Ther. 2021;43 Supl 3:S22
Open access
Loading more articles...
Publish in
Hematology, Transfusion and Cell Therapy
